4//SEC Filing
Forster Eliot 4
Accession 0001415889-25-023708
CIK 0001006281other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:00 PM ET
Size
7.8 KB
Accession
0001415889-25-023708
Insider Transaction Report
Form 4
Forster Eliot
Director
Transactions
- Award
Common Stock
2025-09-03+7,500→ 7,500 total(indirect: By Trust) - Award
Stock Options (Right to Buy)
2025-09-03+15,000→ 15,000 totalExercise: $1.64Exp: 2035-09-03→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Represents restricted shares of common stock awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended (the "Plan"). The restricted shares vest in 12 equal quarterly installments commencing upon the date of grant.
- [F2]The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant.
- [F3]Does not include options to purchase 85,715 shares of common stock at an exercise price equal to $1.75 per share that expire on September 14, 2033,
Documents
Issuer
Protalix BioTherapeutics, Inc.
CIK 0001006281
Entity typeother
Related Parties
1- filerCIK 0001831558
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 5:00 PM ET
- Size
- 7.8 KB